Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SHSE:688393's Gross Margin % is ranked better than 70.06% of 805
companies
in the Medical Devices & Instruments industry
Industry Median: 52.07
vs SHSE:688393: 64.80
Guangzhou LBP Medicine Science & Technology Co had a gross margin of 67.23% for the quarter that ended in Mar. 2026 => Durable competitive advantage
Guangzhou LBP Medicine Science & Technology Co (SHSE:688393) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Guangzhou LBP Medicine Science & Technology Co had a gross margin of 67.23% for the quarter that ended in Mar. 2026 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Guangzhou LBP Medicine Science & Technology Co Gross Margin % Related Terms
Guangzhou LBP Medicine Science & Technology Co Gross Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Guangzhou LBP Medicine Science & Technology Co Gross Margin % Chart
Guangzhou LBP Medicine Science & Technology Co Annual Data
SHSE:688393 vs ISRG, BDX, MDLN: Gross Margin % Comparison
For the Medical Instruments & Supplies subindustry, Guangzhou LBP Medicine Science & Technology Co's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Guangzhou LBP Medicine Science & Technology Co Gross Margin % vs Medical Devices & Instruments Industry
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Guangzhou LBP Medicine Science & Technology Co (SHSE:688393) has a Gross Margin % of 67.23% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Guangzhou LBP Medicine Science & Technology Co and its competitors. This is 15% below median its historical median of 78.85. Over the past decade, Guangzhou LBP Medicine Science & Technology Co's Gross Margin % has ranged from 63.65 to 83.69. According to the industry distribution chart, Guangzhou LBP Medicine Science & Technology Co ranks #241 out of 805 companies in the Medical Devices & Instruments industry, placing it in the top 29.9%.
Is Guangzhou LBP Medicine Science & Technology Co's Gross Margin % too high?
Guangzhou LBP Medicine Science & Technology Co's current Gross Margin % of 67.23% is 15% below median its 10-year median of 78.85. Over the past 10 years, this metric has ranged from a low of 63.65 to a high of 83.69. The Medical Devices & Instruments industry median Gross Margin % is 52.07. Guangzhou LBP Medicine Science & Technology Co's value of 67.23% is 29.1% above this industry median. Based on the distribution chart, Guangzhou LBP Medicine Science & Technology Co ranks #241 out of 805 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Guangzhou LBP Medicine Science & Technology Co has a GF Score™ of 62/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Guangzhou LBP Medicine Science & Technology Co's Gross Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Guangzhou LBP Medicine Science & Technology Co ranks #241 out of 805 companies for Gross Margin %. This puts Guangzhou LBP Medicine Science & Technology Co in the upper half of its industry. The industry median Gross Margin % is 52.07. Guangzhou LBP Medicine Science & Technology Co's value of 67.23% is 29.1% above this benchmark. Historically, Guangzhou LBP Medicine Science & Technology Co's own Gross Margin % has ranged from 63.65 to 83.69 over the past decade. While the company's 10-year median is 78.85 vs. the industry median of 52.07, Guangzhou LBP Medicine Science & Technology Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Medical Devices & Instruments company?
The median Gross Margin % among Medical Devices & Instruments companies is 52.07, based on 805 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Guangzhou LBP Medicine Science & Technology Co's current Gross Margin % of 67.23% is 29.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Guangzhou LBP Medicine Science & Technology Co and its competitors. For the Medical Devices & Instruments industry, the median Gross Margin % is 52.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Guangzhou LBP Medicine Science & Technology Co's current Gross Margin % is 67.23%, which is 15% below median its own 10-year median of 78.85. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Guangzhou LBP Medicine Science & Technology Co stock overvalued right now?
Based on GuruFocus' analysis, Guangzhou LBP Medicine Science & Technology Co (SHSE:688393) is currently considered Significantly Undervalued. The stock's GF Value™ is ¥25.52, compared to a current price of ¥17.17 — trading 32.7% below its estimated fair value. The current Gross Margin % is 67.23%, which is 15% below median its 10-year median of 78.85 and 29.1% above the Medical Devices & Instruments industry median of 52.07. Guangzhou LBP Medicine Science & Technology Co's overall GF Score™ is 62/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Guangzhou LBP Medicine Science & Technology Co (SHSE:688393), the current Gross Margin % is 67.23% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Guangzhou LBP Medicine Science & Technology Co (SHSE:688393) Overvalued in 2026?
Based on GuruFocus' analysis, Guangzhou LBP Medicine Science & Technology Co stock appears to be undervalued.
The current stock price of ¥17.17 is trading 32.7% below its estimated GF Value™ of ¥25.52.
GuruFocus considers Guangzhou LBP Medicine Science & Technology Co to be Significantly Undervalued.
Key valuation signals for SHSE:688393:
Gross Margin %: 67.23% (15% below median its 10-year median of 78.85)
GF Value™: ¥25.52 vs. price of ¥17.17 (32.7% below fair value)
Industry Position: 29.1% above the Medical Devices & Instruments median (#241 of 805)
No single metric tells the full story. See the SHSE:688393 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Guangzhou LBP Medicine Science & Technology Co Business Description
Guangzhou LBP Medicine Science & Technology Co Ltd is engaged in production and sales of in vitro diagnostic reagents and instruments. The company's products include Fluorescence in situ hybridization (FISH) series; Immunohistochemistry (IHC) series; Liquid - based cytology (LBP) series; PCR series; and medical laboratory.
62GF Score
Get the complete analysis for SHSE:688393
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688393 has been successfully added to your 
